Annual Statements Open main menu

AXCELIS TECHNOLOGIES INC - Quarter Report: 2011 September (Form 10-Q)

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended September 30, 2011

 

 

or

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from               to               

 

Commission file number 000-30941

 

AXCELIS TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

34-1818596

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer
Identification No.)

 

108 Cherry Hill Drive
Beverly, Massachusetts 01915

(Address of principal executive offices, including zip code)

 

(978) 787-4000

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x No o.

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

 

Accelerated filer x

 

 

 

Non-accelerated filer o

(Do not check if a smaller reporting company)

 

Smaller reporting company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes o No x

 

As of November 3, 2011 there were 106,475,496 shares of the registrant’s common stock outstanding.

 

 

 



Table of Contents

 

Table of Contents

 

PART I - FINANCIAL INFORMATION

 

Item 1.

Financial Statements (Unaudited)

3

 

Consolidated Statements of Operations for the three and nine months ended September 30, 2011 and 2010

3

 

Consolidated Balance Sheets as of September 30, 2011 and December 31, 2010

4

 

Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010

5

 

Notes to Unaudited Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

 

Overview

12

 

Critical Accounting Estimates

12

 

Results of Operations

13

 

Liquidity and Capital Resources

17

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

18

Item 4.

Controls and Procedures

18

PART II - OTHER INFORMATION

 

Item 1.

Legal Proceedings

19

Item 1A.

Risk Factors

19

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

19

Item 3.

Defaults Upon Senior Securities

19

Item 4.

(Removed and Reserved)

19

Item 5.

Other Information

19

Item 6.

Exhibits

19

 

2



Table of Contents

 

PART 1—FINANCIAL INFORMATION

 

Item 1.    Financial Statements.

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

Revenue

 

 

 

 

 

 

 

 

 

Product

 

$

64,350

 

$

66,162

 

$

235,287

 

$

157,133

 

Service

 

8,105

 

8,944

 

23,718

 

24,676

 

 

 

72,455

 

75,106

 

259,005

 

181,809

 

Cost of revenue

 

 

 

 

 

 

 

 

 

Product

 

40,055

 

47,848

 

149,833

 

111,858

 

Service

 

5,505

 

5,788

 

17,058

 

15,606

 

 

 

45,560

 

53,636

 

166,891

 

127,464

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

26,895

 

21,470

 

92,114

 

54,345

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

11,389

 

9,872

 

35,036

 

28,482

 

Sales and marketing

 

7,237

 

7,151

 

22,731

 

20,361

 

General and administrative

 

8,458

 

7,885

 

25,929

 

23,049

 

 

 

27,084

 

24,908

 

83,696

 

71,892

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(189

)

(3,438

)

8,418

 

(17,547

)

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest income

 

7

 

15

 

24

 

69

 

Other, net

 

1,563

 

(1,996

)

(45

)

(2,061

)

 

 

1,570

 

(1,981

)

(21

)

(1,992

)

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

1,381

 

(5,419

)

8,397

 

(19,539

)

 

 

 

 

 

 

 

 

 

 

Income taxes

 

230

 

854

 

1,207

 

2,364

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

1,151

 

$

(6,273

)

$

7,190

 

$

(21,903

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.01

 

$

(0.06

)

0.07

 

$

(0.21

)

Diluted

 

$

0.01

 

$

(0.06

)

$

0.07

 

$

(0.21

)

 

 

 

 

 

 

 

 

 

 

Shares used in computing basic and diluted net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic weighted average common shares

 

106,417

 

104,628

 

106,152

 

104,307

 

Diluted weighted average common shares

 

108,192

 

104,628

 

109,452

 

104,307

 

 

See accompanying Notes to these Consolidated Financial Statements

 

3



Table of Contents

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

September 30,
2011

 

December 31,
2010

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

44,413

 

$

45,743

 

Accounts receivable, net

 

39,881

 

57,888

 

Inventories, net

 

121,916

 

109,653

 

Prepaid expenses and other current assets

 

9,392

 

15,346

 

Total current assets

 

215,602

 

228,630

 

 

 

 

 

 

 

Property, plant and equipment, net

 

37,896

 

38,594

 

Long-term restricted cash

 

107

 

107

 

Other assets

 

19,064

 

13,541

 

 

 

$

272,669

 

$

280,872

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

17,703

 

$

36,709

 

Accrued compensation

 

13,191

 

10,597

 

Warranty

 

3,639

 

2,556

 

Income taxes

 

777

 

 

Deferred revenue

 

9,857

 

13,859

 

Other current liabilities

 

4,456

 

4,408

 

Total current liabilities

 

49,623

 

68,129

 

 

 

 

 

 

 

Long-term deferred revenue

 

2,087

 

2,417

 

Other long-term liabilities

 

5,190

 

4,759

 

 

 

 

 

 

 

Commitments and contingencies (Note 10)

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock

 

 

 

Common stock

 

107

 

106

 

Additional paid-in capital

 

498,012

 

493,967

 

Treasury stock

 

(1,218

)

(1,218

)

Accumulated deficit

 

(286,330

)

(293,520

)

Accumulated other comprehensive income

 

5,198

 

6,232

 

 

 

215,769

 

205,567

 

 

 

$

272,669

 

$

280,872

 

 

See accompanying Notes to these Consolidated Financial Statements

 

4



Table of Contents

 

Axcelis Technologies, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine months ended
September 30,

 

 

 

2011

 

2010

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

 

$

7,190

 

$

(21,903

)

Adjustments to reconcile net income (loss) to net cash used for operating activities:

 

 

 

 

 

Depreciation and amortization

 

6,180

 

5,367

 

Taxes

 

75

 

 

Stock-based compensation expense

 

3,644

 

2,953

 

Provision for excess inventory

 

661

 

1,734

 

Changes in operating assets & liabilities

 

 

 

 

 

Accounts receivable

 

17,994

 

(21,890

)

Inventories

 

(13,384

)

9,282

 

Prepaid expenses and other current assets

 

5,910

 

(2,747

)

Accounts payable & other current liabilities

 

(15,237

)

20,386

 

Deferred revenue

 

(4,339

)

5,852

 

Income taxes

 

798

 

201

 

Other assets and liabilities

 

(8,640

)

2,357

 

Net cash provided by operating activities

 

852

 

1,592

 

Cash flows from investing activities:

 

 

 

 

 

Expenditures for property, plant, and equipment

 

(1,950

)

(761

)

Decrease in restricted cash

 

 

3,421

 

Net cash provided by (used for) investing activities

 

(1,950

)

2,660

 

Cash flows from financing activities:

 

 

 

 

 

Financing fees and other expenses

 

(199

)

(523

)

Proceeds from exercise of stock options

 

272

 

104

 

Proceeds from Employee Stock Purchase Plan

 

275

 

206

 

Net cash provided by (used for) financing activities

 

348

 

(213

)

Effect of exchange rate changes on cash

 

(580

)

57

 

Net increase (decrease) in cash and cash equivalents

 

(1,330

)

4,096

 

Cash and cash equivalents at beginning of period

 

45,743

 

45,020

 

Cash and cash equivalents at end of period

 

$

44,413

 

$

49,116

 

 

See accompanying Notes to these Consolidated Financial Statements

 

5



Table of Contents

 

Axcelis Technologies, Inc.

 

Notes To Consolidated Financial Statements (Unaudited)

 

Note 1.  Nature of Business and Basis of Presentation

 

Axcelis Technologies, Inc. (“Axcelis” or the “Company”), is a worldwide producer of ion implantation, dry strip and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia.  In addition, the Company provides extensive aftermarket service and support, including spare parts, equipment upgrades, and maintenance services to the semiconductor industry.

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments which are of a normal recurring nature and considered necessary for a fair presentation of these financial statements, have been included. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for other interim periods or for the year as a whole.

 

The balance sheet at December 31, 2010 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in Axcelis Technologies, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2010.

 

Note 2.  Stock-Based Compensation

 

The Company maintains the Axcelis Technologies, Inc. 2000 Stock Plan (the “2000 Plan”), a stock award and incentive plan which permits the issuance of options, restricted stock, restricted stock units and performance awards to selected employees, directors and consultants of the Company. The Company also maintains the Axcelis Technologies, Inc. Employee Stock Purchase Plan (the “ESPP”), an Internal Revenue Code Section 423 plan. The 2000 Plan and the ESPP are more fully described in Note 14 to the consolidated financial statements in the Company’s 2010 Annual Report on Form 10-K.

 

The Company recognized stock-based compensation expense of $1.5 million and $3.6 million for the three and nine months ended September 30, 2011, respectively.  For the three and nine months ended September 30, 2010, the Company recognized stock-based compensation expense of $1.4 million and $3.0 million, respectively.  These amounts include the impact of recognizing compensation expense related to restricted stock units, non-qualified stock options and stock issued under the ESPP. Included in stock-based compensation expense for the nine months ended September 30, 2011 was $0.3 million related to the accelerated vesting of certain options of a former executive of the Company who retired effective March 31, 2011.

 

6



Table of Contents

 

Note 3.  Net Income (Loss) Per Share

 

Basic earnings per share is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased to include incremental common shares that would have been outstanding if the potentially dilutive common shares had been issued. Because the Company had net losses for the three and nine months period ended September 30, 2010, any potentially diluted common shares related to outstanding stock options, restricted stock, restricted stock units and convertible debt have been excluded from the calculation of net loss per share for that period because the effect would be anti-dilutive.

 

The components of net income (loss) per share are as follows:

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

(in thousands, except per share data)

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

Income (loss)

 

$

1,151

 

$

(6,273

)

$

7,190

 

$

(21,903

)

Weighted average common shares outstanding used in computing basic net income (loss) per share

 

106,417

 

104,628

 

106,152

 

104,307

 

Incremental shares

 

1,775

 

 

3,300

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding used in computing diluted net income (loss) per share

 

108,192

 

104,628

 

109,452

 

104,307

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.01

 

$

(0.06

)

$

0.07

 

$

(0.21

)

Diluted

 

$

0.01

 

$

(0.06

)

$

0.07

 

$

(0.21

)

 

Note 4.  Comprehensive Income (Loss)

 

The components of comprehensive income (loss) are as follows:

 

 

 

Three months ended

 

Nine months ended

 

 

 

September 30,

 

September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

(in thousands)

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

1,151

 

$

(6,273

)

$

7,190

 

$

(21,903

)

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

(3,999

)

4,124

 

(1,034

)

21

 

 

 

$

(2,848

)

$

(2,149

)

$

6,156

 

$

(21,882

)

 

7



Table of Contents

 

Note 5.  Inventories

 

The components of inventories are as follows:

 

 

 

September 30,

 

December 31,

 

 

 

2011

 

2010

 

 

 

(in thousands)

 

Raw materials

 

$

82,416

 

$

74,596

 

Work in process

 

34,084

 

29,848

 

Finished goods (completed systems)

 

5,416

 

5,209

 

 

 

$

121,916

 

$

109,653

 

 

When recorded, reserves reduce the carrying value of inventories to their net realizable value.  The Company establishes inventory reserves when conditions exist that indicate inventories may be in excess of anticipated demand or is obsolete based upon assumptions about future demand for the Company’s products or market conditions.  The Company regularly evaluates the ability to realize the value of inventories based on a combination of factors including: forecasted sales or usage, estimated product- end- of- life dates, estimated current and future market value and new product introductions.  Purchasing and usage alternatives are also explored to mitigate inventory exposure.  As of September 30, 2011 and December 31, 2010, inventory is stated net of inventory reserves of $26.7 million and $27.5 million, respectively.

 

Note 6.  Product Warranty

 

The Company generally offers a one year warranty for all of its systems, the terms and conditions of which vary depending upon the product sold. For all systems sold, the Company accrues a liability for the estimated cost of standard warranty at the time of system shipment and defers the portion of systems revenue attributable to the fair value of non-standard warranty.  Costs for non-standard warranty are expensed as incurred. Factors that affect the Company’s warranty liability include the number of installed units, historical and anticipated product failure rates, material usage and service labor costs. The Company periodically assesses the adequacy of its recorded liability and adjusts the amount as necessary.

 

Changes in the Company’s product warranty liability are as follows:

 

 

 

Nine months ended

 

 

 

September 30,

 

 

 

2011

 

2010

 

 

 

(in thousands)

 

Balance at December 31

 

$

2,713

 

$

726

 

Warranties issued during the period

 

3,910

 

2,242

 

Settlements made during the period

 

(4,179

)

(1,356

)

Changes in estimate of liability for pre-existing warranties during the period

 

1,385

 

185

 

Balance at September 30

 

$

3,829

 

$

1,797

 

Amount classified as current

 

$

3,639

 

$

1,629

 

Amount classified as long-term

 

190

 

168

 

Total warranty liability

 

$

3,829

 

$

1,797

 

 

8



Table of Contents

 

Note 7.  Financial Arrangements

 

Bank Credit Facility

 

On April 25, 2011, the Company amended its existing revolving credit facility with a bank. The amended agreement provides for borrowings up to $30 million based primarily on accounts receivable. The facility has certain financial covenants requiring the Company to maintain minimum levels of operating results and liquidity. The agreement will terminate on April 10, 2015. The Company uses the facility to support letters of credit and hedging transactions.

 

At September 30, 2011, the Company’s available borrowing capacity under the amended credit facility was $24.9 million and the Company was compliant with all covenants of the loan agreement.

 

Note 8.  Income Taxes

 

Income tax expense relates principally to operating results of foreign entities in jurisdictions, primarily in Europe and Asia, where the Company earns taxable income. The Company has significant net operating losses in the United States and certain tax jurisdictions and, as a result, does not pay significant income taxes in those jurisdictions. Accordingly, the effective income tax rate is not meaningful.

 

Note 9.  Significant Customers

 

For the three months ended September 30, 2011, three customers accounted for approximately 14.4%, 13.9% and 10.4% of revenue. For the nine months ended September 30, 2011, three customers accounted for 17.9%, 11.4% and 10.4% of revenue. For the three months ended September 30, 2010, one customer accounted for approximately 17.9% of revenue.  For the nine months ended September 30, 2010, one customer accounted for 14.9% of revenue.

 

At September 30, 2011, three customers accounted for 15.3%, 14.1% and 10.4% of consolidated accounts receivable. At September 30, 2010, three customers accounted for 13.8%, 12.4% and 11.1% of consolidated accounts receivable.

 

Note 10.  Contingencies

 

Litigation

 

The Company is, from time to time, a party to litigation that arises in the normal course of its business operations.  The Company is not presently a party to any litigation that it believes might have a material adverse effect on its business operations.

 

Indemnifications

 

The Company’s system sales agreements typically include provisions under which the Company agrees to take certain actions, provide certain remedies and defend its customers against third-party claims of intellectual property infringement under specified conditions and to indemnify customers against any damage and costs awarded in connection with such claims. The Company has not incurred any material costs as a result of such indemnifications and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.

 

9



Table of Contents

 

Note 11.  Revenue Recognition and New Accounting Guidance Recently Adopted

 

The Company’s revenue recognition policy involves significant judgment by management. As described below, the Company considers a broad array of facts and circumstances in determining when to recognize revenue, including contractual future service obligations to the customer, the complexity of the customer’s post delivery acceptance provisions, payment history, customer creditworthiness and the installation process. In the future, if the post delivery acceptance provisions and installation process become more complex or result in a materially lower rate of acceptance, the Company may have to revise its revenue recognition policy, which could delay the timing of revenue recognition.

 

Axcelis’ system sales transactions are made up of multiple elements, including the system itself and elements that are not delivered simultaneously with the system. These undelivered elements might include a combination of installation services and an extended warranty for support and spare parts, all of which are covered by a single sales price. Effective January 1, 2011, the Company adopted Accounting Standards Update, or ASU, No. 2009-13, Multiple Deliverable Revenue Arrangements, as required, using the prospective method.  Accordingly, this guidance is being applied to all system revenue arrangements entered into or materially modified on or after January 1, 2011. The adoption of the amended guidance did not change the accounting for arrangements entered into prior to January 1, 2011. There was no material impact on our financial position, results of operations or cash flows upon adoption and we do not expect adoption will have a material impact on our future reporting periods based on our current practices.

 

The impact of adopting this amended guidance on the Company’s results of operations has been limited to transactions involving the sale of systems. ASU No. 2009-13 amended the previous guidance for multiple-element arrangements.  Pursuant to the amended guidance in ASU 2009-13, the Company’s system revenue arrangements with multiple elements are divided into separate units of accounting if specified criteria are met, including whether the delivered element has stand-alone value to the customer. If the criteria are met, then the consideration received is allocated among the separate units based on their relative selling price, and the revenue is recognized separately for each of the separate units.

 

The Company determines selling price for each unit of accounting (element) using vendor specific objective evidence (VSOE) or third-party evidence (TPE), if they exist, otherwise, the Company uses best estimated selling price (BESP). The Company generally expects that it will not be able to establish TPE due to the nature of its products, and, as such, the Company typically will determine selling price using VSOE or BESP.

 

Where required, the Company determines BESP for an individual element based on consideration of both market and Company-specific factors, including the selling price and profit margin for similar products, the cost to produce the deliverable and the anticipated margin on that deliverable and the characteristics of the varying markets in which the deliverable is sold.

 

The total consideration to be received in the transaction is allocated to each element in the arrangement based upon the relative selling price of each element when compared to the consideration received.

 

Systems are not sold separately and VSOE or TPE is not available for the systems element. Therefore the selling price associated with systems is based on BESP. The allocated value for installation in the arrangement includes (a) the greater of (i) the relative selling price of the installation or (ii) the portion or the sales price that will not be received until the installation is completed (the “retention”). The selling price of installation is based upon the fair value of the service performed, including labor, which is based upon the estimated time to complete the installation at hourly rates, and material components, both of which are sold separately. The selling price of all other elements (extended warranty for support, spare parts, and labor) is based upon the price charged when these elements are sold separately, or VSOE.

 

Product revenue for systems which have demonstrated market acceptance is generally recognized upon shipment provided title and risk of loss has passed to the customer, evidence of an arrangement exists, prices are contractually fixed or determinable, collection is reasonably assured through historical collection results and regular credit evaluations, and there are no uncertainties regarding customer acceptance. Revenue from installation services is recognized at the time formal acceptance is received from the customer or, for certain customers, when both the formal acceptance and retention payment have been received. Revenue for other elements is recognized at the time products are shipped or the related services are performed.

 

10



Table of Contents

 

The Company generally recognizes product revenue for systems which have demonstrated market acceptance at the time of shipment because the customer’s post-delivery acceptance provisions and installation process have been established to be routine, commercially inconsequential and perfunctory. While some customers accept Axcelis’ standard specifications, the majority of Axcelis’ systems are designed and tailored to meet the customer’s specifications, as outlined in the contract between the customer and Axcelis. To ensure that the customer’s specifications are satisfied, some customers request that new systems be tested at Axcelis’ facilities prior to shipment, normally with the customer present, under conditions that substantially replicate the customer’s production environment and the customer’s criteria are confirmed to have been met.  The Company believes the risk of failure to complete a system installation is remote. Should an installation not be completed successfully, the contractual provisions do not provide for forfeiture, refund or other purchase price concession beyond those prescribed by the provisions of the Uniform Commercial Code applicable generally to such transactions.

 

For initial shipments of systems with new technologies or in the small number of instances where Axcelis is unsure of meeting the customer’s specifications or obtaining customer acceptance upon shipment of the system, Axcelis will defer the recognition of systems revenue and related costs until installation is completed and written customer acceptance of the system is obtained. This deferral period is generally within twelve months of shipment.

 

Note 12.  Recent Accounting Pronouncements

 

In June 2011, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2011-05, Comprehensive Income (Topic 220). This newly issued accounting standard (1) eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders’ equity; (2) requires the consecutive presentation of the statement of net income and other comprehensive income; and (3) requires an entity to present reclassification adjustments on the face of the financial statements from other comprehensive income to net income. This update does not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income nor does it affect how earnings per share is calculated or presented. This update is required to be applied retrospectively and is effective for us for fiscal years (and interim periods within those years) beginning on or after January 1, 2012. As this update only requires enhanced disclosure, the adoption of this update will not impact our financial position or results of operations.

 

11



Table of Contents

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Form 10-Q are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth or referred to under “Liquidity and Capital Resources” and “Risk Factors” and others discussed elsewhere in this Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.

 

Overview

 

The semiconductor capital equipment industry is subject to significant cyclical swings in capital spending by semiconductor manufacturers. Capital spending is influenced by demand for semiconductors and the products using them, the utilization rate and capacity of existing semiconductor manufacturing facilities and changes in semiconductor technology, all of which are outside of our control. As a result, our revenue and gross margins fluctuate from year to year and period to period. We typically become more efficient in manufacturing products as they mature. Our operating expense base is largely fixed and does not vary significantly with changes in volume. Therefore, we experience fluctuations in operating results and cash flows depending on our revenue as driven by the level of capital expenditures by semiconductor manufacturers.

 

The sizable expense of building, upgrading or expanding a semiconductor fabrication facility is increasingly causing semiconductor companies to contract with foundries to manufacture their semiconductors. In addition, consolidation and partnering within the semiconductor manufacturing industry is increasing. We expect these trends to continue to reduce the number of our potential customers. This growing concentration of Axcelis’ customers may increase pricing pressure as higher percentages of our total revenue are tied to the buying decisions of a particular customer or a small number of customers.

 

During the three month period ending September 30, 2011, deterioration within the industry environment has decreased our revenues as compared with the prior quarter. Although future market conditions are difficult to predict, we expect revenue to continue to decline in the quarter ending December 31, 2011.  Prior to these changing dynamics, during 2010, the market for our products steadily improved and we gained market share with our single wafer ion implant systems for high current and high energy applications (the Optima HDx and Optima XEx).  In 2011, we continue to penetrate new customers with our Optima implant products, which we expect will lead to additional future sales. We expect to gain market share in 2011 with our Integra dry strip products.  In the event that the industry conditions cause the demand for Axcelis’ products to decline in future periods, we believe we can align manufacturing and operating expense levels to the changing business conditions and provide sufficient liquidity to support operations.

 

Operating results for the periods presented are not necessarily indicative of the results that may be expected for future interim periods or years as a whole.

 

Critical Accounting Estimates

 

Management’s discussion and analysis of our financial condition and results of operations are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on- going basis, we evaluate our estimates, including those related to revenue recognition, income taxes, accounts receivable, inventory and warranty obligations. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

12



Table of Contents

 

There has been no material change in the nature of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2010.

 

Results of Operations

 

The following table sets forth our results of operations as a percentage of revenue for the periods indicated:

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

Percentage of Revenue

(Unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

Revenue

 

 

 

 

 

 

 

 

 

Product

 

88.8

%

88.1

%

90.8

%

86.4

%

Service

 

11.2

 

11.9

 

9.2

 

13.6

 

Total revenue

 

100.0

 

100.0

 

100.0

 

100.0

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

 

 

 

 

 

 

 

Product

 

55.3

 

63.7

 

57.8

 

61.5

 

Service

 

7.6

 

7.7

 

6.6

 

8.6

 

Total cost of revenue

 

62.9

 

71.4

 

64.4

 

70.1

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

37.1

 

28.6

 

35.6

 

29.9

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

15.7

 

13.2

 

13.5

 

15.6

 

Sales and marketing

 

10.0

 

9.5

 

8.8

 

11.2

 

General and administrative

 

11.7

 

10.5

 

10.0

 

12.7

 

Total operating expenses

 

37.4

 

33.2

 

32.3

 

39.5

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(0.3

)

(4.6

)

3.3

 

(9.6

)

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest income

 

0.0

 

0.0

 

0.0

 

0.0

 

Other, net

 

2.2

 

(2.6

)

0.0

 

(1.1

)

Total other income (expense)

 

2.2

 

(2.6

)

0.0

 

(1.1

)

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

1.9

 

(7.2

)

3.3

 

(10.7

)

Income taxes

 

0.3

 

1.2

 

0.5

 

1.3

 

Net income (loss)

 

1.6

%

(8.4

)%

2.8

%

(12.0

)%

 

13



Table of Contents

 

Three and nine months ended September 30, 2011 in comparison to the three and nine months ended September 30, 2010

 

Revenue

 

Product

 

Product revenue, which includes systems sales, sales of spare parts and product upgrades, was $64.4 million, or 88.8% of revenue, for the three months ended September 30, 2011, compared with $66.2 million, or 88.1% of revenue for the three months ended September 30, 2010. Product revenue was $235.3 million, or 90.8% of revenue for the nine months ended September 30, 2011, compared with $157.1 million, or 86.4% of revenue for the nine months ended September 30, 2010.  System sales were $35.1 million, or 48.5% of revenue, for the three months ended September 30, 2011, compared with $39.1 million, or 52.1% of revenue, for the three months ended September 30, 2010.  System sales were $143.7 million, or 55.5% of revenue, for the nine months ended September 30, 2011, compared with $77.3 million, or 42.5% of revenue, for the nine months ended September 30, 2010.  The decrease in product revenue in the three month period ended September 30, 2011 is attributable to the weakening of the semiconductor market and a related delay in capital spending by semiconductor manufacturers, following stronger quarters at the beginning of 2011, as reflected in the nine-month year over year comparisons.  Despite this market slowdown, we believe we are gaining traction with our single wafer ion implant systems and with our dry strip products.

 

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at September 30, 2011 and 2010 was $11.9 million and $11.5 million, respectively.  The slight increase was mainly due to the increase in systems sales in 2011.

 

Service

 

Service revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $8.1 million, or 11.2% of revenue, for the three months ended September 30, 2011, compared with $8.9 million, or 11.9% of revenue, for the three months ended September 30, 2010.  Service revenue was $23.7 million, or 9.2% of revenue for the nine months ended September 30, 2011, compared with $24.7 million, or 13.6% of revenue for the nine months ended September 30, 2010.  Service revenue is affected by the expansion of the installed base of off-warranty systems and can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities.

 

Ion Implant

 

Included in total revenue of $72.5 million for the three month period ended September 30, 2011, is revenue from sales of ion implantation products and service of $51.1 million, or 70.5% of total revenue, compared with $64.2 million, or 85.5% of total revenue, for the three months ended September 30, 2010.  The dollar decrease was due to the factors discussed above for product revenue.  Revenue from sales of ion implantation products and service accounted for $187.8 million, or 72.5% of revenue, for the nine months ended September 30, 2011, compared to $153.2 million, or 84.3% of revenue, in the nine months ended September 30, 2010.  The dollar increase was due to the factors discussed above for product revenue.

 

14



Table of Contents

 

Aftermarket

 

The Company’s product revenues include sales of spare parts and product upgrades as well as complete systems.  We refer to the business of selling spare parts and product upgrades, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business.  Included in total revenue of $72.5 million is revenue from our aftermarket business of $37.3 million for the three months ended September 30, 2011, compared to $36.0 million for the three months ended September 30, 2010.  The revenue from our aftermarket business was $115.4 million for the nine months ended September 30, 2011, compared to $104.5 million for the nine months ended September 30, 2010.  Aftermarket revenue generally increases with expansion of the installed base of systems but can fluctuate period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service.

 

Gross Profit

 

Product

 

Gross profit from product revenue was 37.8% for the three months ended September 30, 2011, compared to gross profit of 27.7% for the three months ended September 30, 2010.  The increase in gross profit of 10.1% is attributable to lower revenue deferrals and favorable absorption of fixed overhead costs which accounted for 7.9%, a higher mix of a parts and upgrade revenue which accounted for 1.8% and a lower provision for excess inventory which accounted for 0.4%.  Gross profit from product revenue was 36.3% for the nine months ended September 30, 2011, compared with 28.8% for the nine months ended September 30, 2010.  The increase in gross profit of 7.5% is attributable to higher systems sales volume and the related favorable absorption of fixed overhead costs which accounted for 16.0% and a lower provision for excess inventory which accounted for 0.5%, offset by a lower mix of parts and upgrade revenue at lower margins which reduced gross profit by 9.0%.

 

Service

 

Gross profit from service revenue was 32.1% for the three months ended September 30, 2011, compared to 35.3% for the three months ended September 30, 2010.  Gross profit from service revenue was 28.1% for the nine months ended September 30, 2011, compared to 36.8% for the nine months ended September 30, 2010.  The decrease in gross profit for the three and nine months ended September 30, 2011, is attributable to lower volumes, higher fixed service costs and changes in the mix and timing of service contracts.

 

Research and Development

 

Research and development expense was $11.4 million in the three months ended September 30, 2011, an increase of $1.5 million, or 15.2%, compared with $9.9 million in the three months ended September 30, 2010. The increase was due to increased payroll costs ($0.6 million) due to increased headcount to support new product development activities, increased project materials and consultants expense ($0.4 million) and increased asset amortization and depreciation costs for assets used as demonstration and/or test systems  ($0.5 million). Research and development expense was $35.0 million for the nine months ended September 30, 2011, an increase of $6.5 million or 22.8%, compared with $28.5 million for the nine months ended September 30, 2010.  The increase was comprised of increased payroll costs ($3.1 million), increased project materials and consultants expense ($2.4 million), and increased development asset amortization and depreciation costs ($1.0 million), substantially all of which are attributable to new product development activities.

 

15



Table of Contents

 

Sales and Marketing

 

Sales and marketing expense was $7.2 million for the three months ended September 30, 2011, equal to the spending in the three months ended September 30, 2010.  Sales and marketing expense was $22.7 million for the nine months ended September 30, 2011, an increase of $2.3 million, or 11.3%, compared with $20.4 million for the nine months ended September 30, 2011.  The increase was primarily due to increased payroll costs ($2.1 million) due to the increased sales volume of our products experienced by the Company during the year, increased commission costs ($0.8 million), increased travel costs of ($0.3 million), increased freight costs ($0.5 million), and decreased supplies and marketing services expense ($1.4 million).

 

General and Administrative

 

General and administrative expense was $8.5 million for the three months ended September 30, 2011, an increase of $0.6 million or 7.6%, compared with $7.9 million in the three months ended September 30, 2010. The increase was due to increased compensation expense due to increased incentive compensation accruals and higher headcount ($1.0 million) and decreased professional services ($0.4 million). General and administrative expense was $25.9 million for the nine months ended September 30, 2011, an increase of $2.9 million, or 12.6%, compared with $23.0 million in the nine months ended September 30, 2010.  The increase was due to increased compensation expense due to increased incentive compensation expense and higher headcount ($3.0 million) and separation costs associated with the retirement of a former executive of the Company ($0.3 million) and decreased professional services ($0.4 million).

 

Other Income (Expense)

 

Other income was $1.6 million for the three months ended September 30, 2011 compared with other expense of $2.0 million for the three months ended September 30, 2010.  Other income (expense) for the three months ended September 30, 2011 primarily consisted of foreign exchange gains compared to foreign exchange losses in 2010, as a result of U.S. dollar currency fluctuations against the local currencies of certain of the countries in which we operate.

 

For the three and nine months ended September 30, 2011 the Company incurred $1.8 million and $0.7 million of foreign exchange gains.  For the three and nine months ended September 30, 2010 the Company incurred $1.5 million and $0.9 million of foreign exchange losses.

 

16



Table of Contents

 

Income Taxes

 

We incur income tax expense relating principally to operating results of foreign entities in Europe and Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain European tax jurisdictions, and, as a result, we do not currently pay significant income taxes in those jurisdictions. Additionally, we do not recognize the tax benefit for losses in the United States and certain European tax jurisdictions. Accordingly, our effective income tax rate is not meaningful.

 

Liquidity and Capital Resources

 

We believe that based on our current market, revenue and expense forecasts, our existing cash and cash equivalents, and available credit will be sufficient to satisfy our anticipated cash requirements for the foreseeable future. The Company is also exploring a sale - leaseback transaction of our Beverly, MA facility which would further strengthen our cash position. Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of acceptance of our Optima and Integra product lines, and others relate to the uncertainties of global economies, including the availability of credit and the condition of the overall semiconductor equipment industry.

 

During the nine months ended September 30, 2011, $0.9 million of cash was generated to support operating activities, including increased levels of inventories in anticipation of future system sales.  Cash and cash equivalents at September 30, 2011 were $44.4 million, compared to $45.7 million at December 31, 2010. In the event that demand for Axcelis’ products declines in future periods, the Company believes it can align manufacturing and operating spending levels to the changing business conditions and provide sufficient liquidity to support operations.

 

On April 25, 2011, the Company amended its existing revolving credit facility with a bank. The amended agreement provides for borrowings up to $30 million based primarily on accounts receivable. The facility has certain financial covenants requiring us to maintain minimum levels of operating results and liquidity. The agreement will terminate on April 10, 2015. The Company uses the facility to support letters of credit and hedging transactions.

 

At September 30, 2011 the Company’s available borrowing capacity under the amended credit facility was $24.9 million and the Company was compliant with all covenants of the loan agreement.

 

Commitments and Contingencies

 

Significant commitments and contingencies at September 30, 2011 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010.

 

17



Table of Contents

 

Item 3.    Quantitative and Qualitative Disclosures about Market Risk.

 

As of September 30, 2011, there have been no material changes to the information about market risk disclosed in Item 7A to our annual report on Form 10-K for the year ended December 31, 2010.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the third quarter of 2011 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18



Table of Contents

 

PART II — OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

The Company is not presently a party to any litigation that it believes might have a material adverse effect on its business operations.  The Company is, from time to time, a party to litigation that arises in the normal course of its business operations.

 

Item 1A.  Risk Factors.

 

As of September 30, 2011, there have been no material changes to the risk factors described in Item 1A to our annual report on Form 10-K for the year ended December 31, 2010.

 

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3.  Defaults Upon Senior Securities.

 

None.

 

Item 4.  (Removed and Reserved).

 

Item 5.  Other Information.

 

None.

 

Item 6.    Exhibits.

 

The following exhibits are filed herewith:

 

Exhibit
No

 

Description

3.1

 

Amended and Restated Certificate of Incorporation of the Company. Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the Commission on May 11, 2009.

 

 

 

3.2

 

Bylaws of the Company, as amended as of August 8, 2007. Incorporated by reference to Exhibit 3.2 of the Company’s Form 10-Q for the quarter ended June 30, 2007, filed with the Commission on August 9, 2007.

 

 

 

31.1

 

Certification of the Principal Executive Officer under Exchange Act Rule 13a-14(a)/15d-14(a) (Section 302 of the Sarbanes-Oxley Act), dated November 4, 2011. Filed herewith.

 

 

 

31.2

 

Certification of the Principal Financial Officer under Exchange Act Rule 13a-14(a)/15d-14(a) (Section 302 of the Sarbanes-Oxley Act), dated November 4, 2011. Filed herewith.

 

 

 

32.1

 

Certification of the Principal Executive Officer pursuant to Section 1350 of Chapter 63 of title 18 of the United States Code (Section 906 of the Sarbanes-Oxley Act), dated November 4, 2011. Filed herewith.

 

 

 

32.2

 

Certification of the Principal Financial Officer pursuant to Section 1350 of Chapter 63 of title 18 of the United States Code (Section 906 of the Sarbanes-Oxley Act), dated November 4, 2011. Filed herewith.

 

 

 

101

 

The following materials from the Company’s Form 10-Q for the quarter ended September 30, 2011, formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Statements of Operations, (ii) Consolidated Balance Sheets, (iii) Consolidated Statements of Cash Flows and (iv) Notes to Consolidated Financial Statements.

 

 

 

 

 

Exhibit 101 includes:

 

 

 

 

 

101.INS

 

XBRL Instance Document. Filed herewith.

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document. Filed herewith.

 

 

101.DEF

 

XBRL Taxonomy Definition Linkbase Document. Filed herewith.

 

 

101.CAL

 

XBRL Taxonomy Calculation Linkbase Document. Filed herewith.

 

 

101.LAB

 

XBRL Taxonomy Label Linkbase Document. Filed herewith.

 

 

101.PRE

 

XBRL Taxonomy Presentation Linkbase Document. Filed herewith.

 

19



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

AXCELIS TECHNOLOGIES, INC.

 

 

 

/S/  JAY ZAGER

 

 

 

DATED: November 4, 2011

By:

Jay Zager

 

 

Executive Vice President and Chief Financial Officer

 

 

Duly Authorized Officer and Principal Financial Officer

 

20